Supporting this possibility are previous findings indicating that high levels of TNF-alpha and IL-6 correlate negatively with T cell numbers in severe COVID-19 in the general population (30), and that B cell numbers and antibodies are reduced in COVID-19 patients with hematologic malignancies (17). This evidence concerns the gene TNF and hematologic disorder.